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Summary: The sensitivity and specificity of two non-radioactive spot hybridization assays for hepatitis B virus
DNA (HBV-DNA) using biotin and digoxygenin-labelled DNA probes were investigated in parallel in 122
serum samples from patients with chronic hepatitis B and 50 controls. The results were compared with an
isotopic technique using a 32P-labelled probe.
HBV-DNA was detected in 56 (80%) out of 70 hepatitis B "e" antigen (HBeAg)-positive cases and in 4 (8%)
out of 52 antibody to hepatitis B "e" antigen (anti-HBe)-positive cases using the digoxygenin or 32P-labelled
probes. No false positives were found with either method. Using the biotin-labelled probe, 16% of sera gave
discordant results, which were considered to be false positive. The time required for detection of serum HBV-
DNA was 2 hours for the non-radioactive probes and 16 hours for the isotopic probes.
This study suggests that the digoxygenin-labelled probe for detection of HBV-DNA is the most rapid and
sensitive method for routine diagnosis of viral replication in clinical laboratories.
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 tin or digoxygenin-labelled nucleotides by enzymatic
Detection of hepatitis B virus (HBV) DNA in serum reaction (8 — 10). Some of these techniques have
provides an important diagnostic tool for studying proved to be slightly less sensitive than the radioactive
viral replication in chronic hepatitis B (l, 2). Nucleic methods in HBV-DNA detection (11, 12).
acid hybridization techniques using 32P-labeIled
probes are commonly used for routine analysis be- Our interest resides in finding accurate and rapid non-
cause they are rapid, require smalbamounts of serum radioactive methods suitable for routine diagnosis in
and allow simultaneous treatment of about one clinical laboratories, for HBV-DNA detection in hu-
hundred samples (3, 4). Their disadvantage lies in the man serum samples. In this work we investigate and
use of radioisotopes, which have short half-lives, are compare the sensitivity, the specificity and the time
expensive and cannot be handled easily in a routine necessary for detection of HBV-DNA, using DNA
diagnostic laboratory. A variety of methods have been probes prepared by: incorporation of biotin (biotin-
proposed to replace the radioactive labelling of 11-dUTP) into DNA by Standard nick-translation
probes, such s the chemical modification of detect- procedures; incorporation of digoxygenin (digoxy-
able DNA with monoclonal antibodies, fluorescein genin-dUTP) into DNA by random priming; and a
and photobiotin (5—7), and the incorporation of bio- Standard radioactive 32P nick-translation procedure.
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Patients and Methods
Two groups of patients were studied:
Group I comprised 122 palients with chronic hepalitis type B,
s documented by the presence of hepatitis B surface antigen
(HBsAg) and elevated alanine aminotransferase levels in serum
for at least 6 months. Most of them had histological evidence
of chronic hepatitis or cirrhosis. Seventy (57%) were HBeAg-
positive and 52 (42%) were anti-HBe-positive. The alanine
aminotransferase levels in HBeAg-positive patients were: mean
76 U/l; r nge 40-210 U/l. The corresponding values in the
anti-HBe-positive group were: mean 84 U/l; r nge 35 — 84 U/l.
Group II (control group) included 30 patients with chronic
hepatitis, 28 with antibodies to hepatitis C virus (alanine ami-
notransferase r nge 60- 248 U/l, mean 153 U/l) and 20 clini-
cally healthy blood donors (alanine aminotransferase levels
within the normal r nge). None of the 50 control subjects had
serological markers of HBV infection.
Hepatitis B virus markers
The hepatitis B surface antigen (HBsAg), the hepatitis B V
antigen (HBeAg), the antibody to hepatitis B "core" antigen
(anti-HBc) and the antibody to hepatitis B "e" antigen (anti-
HBe) were determined using commercial radioimmunoassays
(Abbott Laboratories, North Chicago, ILL).
Nucleic acid hybr idiza t ion
The nkrocellidose filters were always prehybridized for at least
2h in a solution containing 12.5 mol/1 formamide, 0.75 mol/1
NaCl, 0.075 mol/1 sodium citrate, 0.02 mol/1 Na phosphate (pH
6.5), 5 χ Denhart's and 100 mg/1 salmon sperm DNA at 42 °C.
Hybridization was carried out in the same solution with either
100 μg/l of non-radioactive probe or 10 μg/l of radioactive
probe. The filters were washed in a solution containing 0.015
mol/1 Neck, 0.0015 sodium citrate; Ό.0034 mol/1 SDS and then
air dried.
Detection of bound labelled DNA probes
The fllters hybridized with the radioactive DNA probe were
autoradiographed at -70°C with Kodak XAR-S film and
Micron R intensifying screen.
Positive hybridization with biptin-labelled probes was visual-
ized by incubation with streptavidin/alkaline phosphatase con-
jugate followed by coloured enzymatic reaction (5-bromo-4
chloro-3-indolyl phosphate and nitroblue tetrazolium salt)
(BRL).
The detection of digoxygenin-labelled DNA was carried out by
enzym-linked immunoassay using an antibody-conjugate (an-
tidigoxygenin alkaline phosphatase conjugate) and the above
described colorimetric reaction (Boehringer Mannheim, SA).
Label l ing of DNA probes
Plasmid pcF80, containing four copies of cloned HBV-DNA,
was kindly provided by Dr. Brechot (Institut Pasteur, Paris,
France) (13). The plasmid DNA was digested with Eco RI and
subjected to agarose electrophoresis. The HBV-DNA was re-
tained in DEAE-cellulose and eluted by incubation in a buffer
containing 1.5 mol/1 NaCl buffer 10 mmol/1 Tris · HC1 (pH
7.5), l mmol/1 EDTA at 37 °C.
Labelling of DNA probes was carried out s previously de-
scribed (14, 15). Briefly:
a) Radioactive (32P) probe: For the isotopic labelling, 32P-dATP
(Amersham Corporation, Illinois, U. S. A.) was incorporated
into HBV-DNA (0.1 μg) by nick-translation, s recommended
by the manufacturer of the kit (Nick Translation Reagent Kit,
BRL). The specific activity obtained was 4 χ l O8 counts/min
per g.
b) Biotin-labelled probe: For the non-isotopic labelling, biotin-
11 dUTP (BRL) was incorporated into the HBV-DNA (0.3 μg)
by nick-translation according to the manufacturer's recommen-
dations (BRL). The biotin-labelled probes were stored at
— 20 °C. Their stability was tested in repeated assays for several
months.
c) Digoxygenin-labelled probes: The HBV-DNA (0.3 μg) was
labelled by "random primed" incorporation of digoxygenin-
dUTP following the instructions of the supplier (Boehringer
Mannheim, SA).
Preparation of serum samples
Sera were prepared according to Scotio et al. (3), with some
modifications. Briefly, 7 μΐ of serum were directly denatured in
0.5 mol/1 NaOH, 1.5 mol/1 NaCl (final volume of 200 μΐ) for
10 min, filtered on a nitrocellulose membrane (Schleieher &
Schuell, B A 85) and neutralized by immersion in 0.5 mol/1 Tris
• HC1 (pH 7.5), 1.5 mol/1 NaCl for 10 min. Filters were baked
at80 °Cfor2h.
Determination of sensitivity and specificity
The sensitivity of eaeh technique was determined by testing in
duplicate decreasing dilutions (200 to 0.1 pg) of plasmid DNA
pcF 80 in negative control serum samples. As a negative control
plasmid pBR 322 at a concentration of 200 pg was used.
To verify the specificity of the assay, fractions of the serum
samples that had given a positive test result for HBV-DNA
were deproteinized by digestion with proteinase K (40 mg/1)
for 60 min at 37 °C, extracted with phenol/chloroform, and
precipitated with ethanol. The resulting purified DNA was
dissolved in water, denatured and applied to nitrocellulose
filters. It was then tested in the same way s the serum samples.
Results
Sensitivity and time required for testing
The 32P-labelled probe and digoxygenin-labelled
probe were able to detect s little s l pg of cloned
HBV-DNA in the spot hybridization test, while the
biotin-labelled probe was able to detect 5 pg.
The time required for detection of serum HBV-DNA
was 2—3 hours for the non^radioactive probes and
16 hours for the isotopic probe (autoradiogr phy).
Comparison of hybridization results with irn-
munological markers
HBV-DNA was detected in 60 (49%) of 122 HBsAg-
positive serum samples with the 32P and digoxygenin-
labelled probes, and in 79 (64%) sera with the biotin-
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Tab. 1. Comparison of resuUs obtained with biotin, digoxygenin and 32P-labelled probes. The detection of HBV-DNA in serum
is relatcd to serological Status on 88 scrum samples.
N Immunological markers HBV-DNA detection
Biotin
* 8 of these were found be negative after deproteinization.
** 11 of these were found to be negative after deproteinization.
Digoxygenin 32p
70
52
30
20
HBsAg + /HBeAg +
HBsAg + /anti-HBe +
HBsAg -/anti-HBc -
Blood-donors
*74(91%)
**15 (29%)
0
0
56 (80%)
4 (8%)
0
0
56 (80%)
4 (8%)
0
0
labelled probe. Fifty six (80%) serum samples from
70 HBeAg-positive chronic hepatitis patients were
found to be positive for HBV-DNA by the three
methods and 8 (11%) more by the biotin-labelled
probe, exclusively. In 52 anti-HBe-positive patients,
HBV-DNA was found to be positive in 4 (8%) serum
samples by the three methods and 11 (21%) more
only by the biotin-labelled probe (tab. 1). Figure l
demonstrates the results of sera HBV-DNA detection
by the three hybridization methods.
After deproteinization, 19 serum samples, 8 from the
HBeAg-positive and 11 from the anti-HBe-positive
group, which had previously given a positive test
result by the biotin-labelled method, were found to
be negative; these cases were considered to be false-
positive (tab. 1). There were no false positive results
with the 32P or digoxygenin-labelled methods.
None of the three techniques indicated the presence
of HBV-DNA in the 30 samples from patients with
chronic hepatitis without HBV markers, or in the 20
healthy subjects.
Discussion
Our results demonstrate that the non-radioactive tech-
niques for detecting HBV-DNA in serum are a suit-
able alternative to the 32P-labelled probe because they
are sensitive, rapid and reproducible. Of the non-
radioactive probes, the best results were obtained with
the digoxygenin-labelled probe, which permitted de-
tection of äs little äs l pg of HBV-DNA. This reached
the sensitivity level of the 32P-labelled probe without
the inconvenience of exposure to radiation. An ad-
ditional advantage is the comparatively rapid detec-
tion for these methods (2 — 3 hours). The biotin-la-
belled probe give a quick result, but the absolute
sensitivity of the assay was about 5 times lower than
that of the 32P- or digoxygenin-labelled probes. Re-
garding specificity, the biotin-labelled probe produced
16% false positive results, while the 32P- and digoxy-
genin-labelled probes produced no false positives. The
deproteinization Step improved the specificity of the
biotin-labelled technique, but represented on increase
in both cost and time. Our results for specificity and
sensitivity with the digoxygenin-labelled assay are in
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Fig l Comparison of the detection methods. Serum samples from 25 patients were spotted on each of the three hybridization
filtere Filter A was hybridized with a »P-labelled probe. Filter B was hybridized with a biotin-labelled probe and filter
C was hybridized with a digoxygenin-labelled probe. The (a-e) and (1-5) series indicate the positions of the serum
samples in the dot-blot apparatus.
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agreement with several studies of hybridization "in
sitiT, and hybridization of DNA sequences amplified
by polymerase chain reaction (PCR) (16 — 18).
Another advantage of the non-radioactive techniques
is that the hybridization conditions may be standard-
ized; biotin and digoxygenin have relatively longer
half-lives, while 32P has a half-life of about two weeks.
Thus, detection of HBV-DNA is easier, requires less
time and money, and can be used in laboratories
without special facilities. We found the colorimetric
revelation of both digoxygenin and biotin to be of
high quality and comparable to autoradiography; this
agrees with results published by Leary et al. using
other non-radioactive probes (19).
In earlier studies, serum HBeAg detection has been
associated with HBV multiplication, hepatic damage
and serum infectivity. However, the detection of sera
HBeAg does not always indicate viral replication (3,
20). Indeed, serum HBV-DNA negativity may precede
seroconversion from HBeAg to antiHBe; conversely,
HBV-DNA positivity in anti-HBe-positive subjects
with chronic hepatitis, may indicate persistent HBV
replication (18). These possibilities have been con-
firmed using our non-radioactive spot test: 80% of
the 70 HBeAg carriers were positive for HBV-DNA
and 8% of the 52 anti-HBe-positive carriers were
positive for HBV-DNA.
In conclusion, the most efficient non-radioactive
method in our hands was the immunological detection
of digoxygenin-labelled DNA, whieh demonstrated a
sensitivity comparable to the isotöpic technique, and
better speeificity than biotin-labelled DNA, suggest-
ing that this method could be a useful tool for clinical
diagnosis and monitoring of viral replication in
chronic type B hepatitis.
Acknowledgement
This work was supported in part by a grant from FISS 90-0938.
The authors wish to thank Montserrat Gimferrer and Carmen
Molinos for their nursing assistance.
References
1. Brechot, C., Hadchoel, M., Scotto, J., Degos, F., Charnay,
R, Trepo, C. & Tiollais, P. (1981) Detection of hepatitis B
virus DNA in liver and serum: a direct appraisal of the
chronic carrier state. Lancet 2, 765—767.
2. Bonino, F., Hoyer, B., Nelson, J., Engle, R., Vernie, G. &
Gerin, J. (1981) Hepatitis B virus DNA in the sera of
HBsAg carriers: a marker of active hepatitis B virus repli-
cation in the liver. Hepatology 7, 386—391.
3. Scotto, J., Hadchouel, M., Hery, C., Yvart, J., Tiollais, R
& Brecht, C. (1983) Detection of hepatitis B virus DNA in
serum by a simple spot hybridization technique: Compar-
ison with results for other viral markers. Hepatology 3,
279-284.
4. Lieberman, H. M., Labrecque, D. R., Kew, M. C., Had-
zyiannis, S. J. & Shafritz, D. A. (1983) Detection of hep-
atitis B virus DNA directly in human serum by a simplified
molecular hybridization test: Comparison to HBeAg/
antiHBe Status in HBsAg carriers. Hepatology 39 285-
291.
5. Tchen, R, Fuchs, R. R, Sage, E. & Leng, M. (1984) Chem-
ically modified nucleic acids äs immunodetectable probes
in hybridization experiments. Proc. Natl. Acad. Sei. USA
57,3466-3470.
6. Agrowal, S., Cristodoulou, C. & Gait, M. (1984) Efficient
method for DNA hybridization. Nucleic Acid Res. 72,
3435-3444.
7. Foster, A. C., Mclnnes, J. L., Skingle, O. C. & Symons, R.
H. (1985) Non-radioactive hybridization probes prepared
by the chemical labelling of DNA or RNA with a novel
reagent photobiotin. Nucleic Acid Res. 73, 745—761.
8. Viscidi, R. R, Connelly, C. J. & Yolken, R. H. (1986) Novel
chemical method for the preparation of nucleic acid for
non-isotopic hybridization. J. Clin. Microbiol. 23, 311 —
317.
9. Dooley, S., Radtke, J., Blin, N. & Unteregger, G. (1988)
Rapid detection of DNA-binding factors using prqtein-
blotting and digoxygenin-UTP marked probes. Nucleic
Acids Res. 16, 11829.
10. Holtke, H. J., Seibl, R., Burg, J., Muhlegger, IC. & Kessler,
C. (1990) Non-radioactive labeling and detection of nucleic
acids: II optimization of the digoxygenin System. Biol.
Chem. Hoppe-Seyler 577, 929-938.
11. Larzul, D., Thiers, V., Courouce, A. M., Brechot, C. &
Guesdon, J. L. (1987) Non-radioactive hepatitis B virus
DNA probes for detection of HBV-DNA in serum. J.
Hepatol. 57, 199-204.
12. Quibriac, M., Petitjean, J., Novel, M. & Freymuth, F.
(1987) Non radioactive spot hybridization test for detection
of hepatitis B virus DNA in serum. Ann. Inst. Pasteur 138,
377-384.
13. Charnay, R, Pourcel, C. & Fritseh, A. (1980) Cloning in
E. coli and physical structure of hepatitis B virus DNA.
•Proc. Natl. Acad. Sei. USA 76, 2222-2226.
14. Cäsacuberta, J. M., Jardi, R., Buti, M., Puigdomenech, P.
& Sansegundo, B. (1988) Comparison of different non-
isotopic methods for hepatitis B virus detection in human
serum. Nucleic Acids Res. 16, 11834.
15. Genesca, J., Jardi, R., Buti, M., Vives, L., Prat, S., Esteoan,
J. L, Esteban, R. & Güardia, J. (1987) Hepatitis B virus
replication in acüte B, apute hepatitis B virus-hepatitis delta
virus coinfection and acute hepatitis delta superinfeetion.
Hepatology 7, 569-572.
16. Leary, J., Brigati, D. J. & Wards, D. C (1983) Rapid and
sensitive colorimetric method for visualizing biotin-labeled
DNA probes hybridized to DNA or RNA immobilized on
nitrocellulose: Bio-blots. Proc. Natl. Acad. Sei. USA 80,
4045-4049.
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 29,1991 / No. 11
Buti et al.: Digoxygenin-labelled DNA probe for HBV-DNA detection 735
17. Heiles, H. B. J., Genersch, E., Kessler, C., Neumann, R. & 20. Hadzyyannis, S. J., Lieberman, H. M., Karvountzis, G. C.
Eggers, H. J. (1988) In situ hybridization with digoxygenin- & Shafritz, D. A. (1983) Analysis of liver disease, nuclear
labeledDNAofhumanpapillomavirusesinHeLaandSiHa HBcAg, vkal replication, and hepatitis B virus DNA in
cells. BioTechniques (5,978—981. llver and serum of HBeAg/antiHBe positive carriers of
18. Gentilomi, G., Musiani, M., Zerbini, M., Gallinella, G., hepatitis B virus. Hepatology 3, 656—662.
Gibellini, B. & La Placa, M. (1989) A hybrido-immuno- 21. Lok, A. S. F., Hadziyannis, S. J. & Weller, I. V. D. (1984)
cytochemical assay for the in situ detection of cytomega- Contribution of low level HBV replication to continuing
lovirus DNA using digoxygenin-labelled probes. J. Immu- inflammatory activity in patients with anti-HBe positive
nol. Methods 725, 177-183. chronic hepatitis B virus infection. Gut 25, 1283-1287.
19. Kion, T. & Haas, O. A. (1990) Nonradioactive labeling of
probe with digoxygenin by polymerase chain reaction. Maria Buti
Anal. Biochem. 188, 335—337. Servicio de Hepatologia
Hospital General Valle de Hebron
Paseo Valle de Hebron s/n
Barcelona 08035
Spain
Ew. J. Clin. Chem. Clin. Biochem. / Vol. 29,1991 / No. 11

